Stay updated on Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.

Latest updates to the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision history shows the addition of v3.3.2 and the removal of v3.2.0. These are minor maintenance updates and do not affect the study details or user actions.SummaryDifference0.1%

- Check28 days agoChange DetectedAdded an 'Last Update Posted (Estimated)' timestamp to the Study Record Dates and removed a general government funding operating-status notice; the study details, eligibility criteria, and treatments remain unchanged.SummaryDifference0.4%

- Check36 days agoChange DetectedThe page status changed from Recruiting to Active, not recruiting, with dates 2025-11-06 (Actual) and 2025-11-05. Additionally, contact details for the Study Contact and Study Contact Backup were removed.SummaryDifference3%

- Check43 days agoChange DetectedThe main study details appear unchanged; only minor formatting changes and a new last update timestamp are visible.SummaryDifference0.4%

- Check71 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check79 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, with new contact emails and phone numbers added.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.